{"id":"NCT01433107","sponsor":"Novartis","briefTitle":"Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of Terbinafine Film Forming Solution, 1% (as Hydrochloride), in Patients With Tinea Pedis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-08","primaryCompletion":"2012-02","completion":"2012-02","firstPosted":"2011-09-13","resultsPosted":"2013-12-27","lastUpdate":"2013-12-27"},"enrollment":290,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Tinea Pedis"],"interventions":[{"type":"DRUG","name":"Terbinafine","otherNames":[]},{"type":"DRUG","name":"Terbinafine Placebo","otherNames":[]}],"arms":[{"label":"Terbinafine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will compare the efficacy and safety of a single dose of terbinafine film forming solution 1% with a single dose of placebo film forming solution in the treatment of tinea pedis.","primaryOutcome":{"measure":"Effective Treatment Outcome (Direct Microscopy and Culture Negative and Total Signs and Symptom Score Less or Equal to 2)","timeFrame":"week 6","effectByArm":[{"arm":"Terbinafine","deltaMin":73,"sd":null},{"arm":"Placebo","deltaMin":10,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":7},"locations":{"siteCount":6,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":146},"commonTop":["General Disorders"]}}